These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2417016)

  • 41. [Method of determination of protamine titre].
    Kriazhev LN; Timofeev GA
    Lab Delo; 1978; (7):434-5. PubMed ID: 80488
    [No Abstract]   [Full Text] [Related]  

  • 42. [Changes in coagulation and fibrinolysis after open-heart surgery].
    Derman U
    Turk Tip Cemiy Mecm; 1967 Apr; 33(4):227-38. PubMed ID: 6063928
    [No Abstract]   [Full Text] [Related]  

  • 43. [Impaired hemostasis as a cause of intensified bleeding after heart surgery with extracorporeal blood circulation].
    Morozov IuA; Charnaia MA; Gladysheva VG
    Anesteziol Reanimatol; 2004; (2):30-2. PubMed ID: 15206273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rebound anticoagulation occurring after regional heparinization for hemodialysis.
    Blaufox MD; Hampers CL; Merrill JP
    Trans Am Soc Artif Intern Organs; 1966; 12():207-9. PubMed ID: 5960705
    [No Abstract]   [Full Text] [Related]  

  • 45. [Determination of the level of heparin in the blood in the case of extracorporeal circulation during cardiac surgery].
    BLOMBAECK M; BLOMBAECK B; WALLEN P
    Rev Hematol; 1955; 10(1):45-54. PubMed ID: 14385434
    [No Abstract]   [Full Text] [Related]  

  • 46. [Influence of extracorporeal circuits surface on hemostasis system during off-pump surgeries].
    Charnaia MA; Morozov IuA; Gladysheva VG; Laptiĭ AV
    Khirurgiia (Mosk); 2006; (11):14-7. PubMed ID: 17159870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Blood affinity for oxygen and cardiac surgery with extracorporeal circulation].
    Joly JB; Pochard G
    Poumon Coeur; 1971; 27(7):691-4. PubMed ID: 5144944
    [No Abstract]   [Full Text] [Related]  

  • 48. [On 566 cardiac operations under extracorporeal circulation carried out with blood preserved for 18 to 48 hours in acid citrate dextrose (A.C.D.) solution. (Study of chemical and enzymatic modifications and coagulation disorders)].
    Revol L; Termet H; Vittoz P; Thouverez JP; Mikaeloff P; Counitchansky M
    Bibl Haematol; 1968; 29():739-45. PubMed ID: 5728117
    [No Abstract]   [Full Text] [Related]  

  • 49. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Heparin kinetics and methods of heparinization during haemodialysis (author's transl)].
    Lopot F
    Cas Lek Cesk; 1980 Feb; 119(5):139-44. PubMed ID: 7379103
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical and experimental study on the concentration of exogenous heparin in the blood in extracorporeal circulation].
    Kimura T
    Igaku Kenkyu; 1969 Jan; 39(1):16-34. PubMed ID: 5814592
    [No Abstract]   [Full Text] [Related]  

  • 52. [Abnormal platelet function after heart surgery with extracorporeal circulation].
    Bachmann F; McKenna R; Whitaker B
    Schweiz Med Wochenschr; 1974 Sep; 104(39):1374-5. PubMed ID: 4423158
    [No Abstract]   [Full Text] [Related]  

  • 53. Absorption of heparin by kaolin.
    Barrowcliffe TW; Sims GE
    Thromb Haemost; 1976 Nov; 36(2):483-4. PubMed ID: 1036847
    [No Abstract]   [Full Text] [Related]  

  • 54. Disseminated intravascular coagulation following extracorporeal circulation.
    Boyd AD; Engelman RM; Beaudet RL; Lackner H
    J Thorac Cardiovasc Surg; 1972 Nov; 64(5):685-93. PubMed ID: 5083574
    [No Abstract]   [Full Text] [Related]  

  • 55. [The determination of heparin].
    Aiach M
    Ann Biol Clin (Paris); 1982; 40(6):645-50. PubMed ID: 7165134
    [No Abstract]   [Full Text] [Related]  

  • 56. [Safety of continuous epidural anesthesia during heart surgery--change of coagulation-fibrinolysis under heparinization].
    Maeda M; Kosaka Y; Kushizaki H; Yamamori Y; Hashimoto K; Saito Y
    Masui; 1999 Jul; 48(7):723-30. PubMed ID: 10434512
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A new method for the control of heparin therapy].
    Hrcková V; Kousalová J
    Vnitr Lek; 1976 Jan; 22(1):49-51. PubMed ID: 1251560
    [No Abstract]   [Full Text] [Related]  

  • 58. Monitoring heparin therapy.
    Stevens DJ; Latorraca R
    Wis Med J; 1977 Mar; 76(3):33-6. PubMed ID: 842040
    [No Abstract]   [Full Text] [Related]  

  • 59. Rationale and usefulness of heparinization: an overview.
    Palmer RL
    Tex Med; 1977 May; 73(5):68-72. PubMed ID: 860281
    [No Abstract]   [Full Text] [Related]  

  • 60. [Activated coagulation time under heparin therapy in surgical diseases (author's transl)].
    Matsuda M; Tatsuta N; Aoshima M; Nagai T; Daitoh N
    Nihon Geka Hokan; 1977 Mar; 46(2):113-20. PubMed ID: 561580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.